Notably, SERPINH1 expression did not show significant changes in precancerous lesion samples from the GSE63514 dataset (Fig 1D), suggesting that its dysregulation is specific to malignant tumor phenotypes rather than early precancerous stages. This evidence concerns the gene SERPINH1 and neoplasm.